Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSSE Regulatory News (SSE)

Share Price Information for SSE (SSE)

Share Price is delayed by 15 minutes
Get Live Data
2,396.00    36.00 (1.53%)
Bid:
2,385.00
Ask:
2,386.00
Spread: 1.00 (0.042%)
Market Cap: £28.90b
SSE Live PriceLast checked at - London Stock Exchange

Intraday SSE Share Chart

Non-Discretionary Share Buyback Programme

30 Sep 2019 17:33

RNS Number : 2291O
SSE PLC
30 September 2019
 

Announcement of Non-Discretionary Share Buyback Programme

SSE plc (the 'Company') confirmed on 30 August 2019 that, in light of the SCRIP take up of the 2018/19 dividend exceeding 20%, it intends to buy-back shares in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 18 July 2019, the EU Market Abuse Regulation and Chapter 12 of the Listing Rules.

In line with this, today the Company announces in compliance with the EU Market Abuse Regulation that it has instructed Morgan Stanley & Co. International plc ('Morgan Stanley') and Credit Suisse Securities (Europe) Limited ('Credit Suisse') in relation to an irrevocable, non-discretionary programme to repurchase its ordinary shares for cancellation (the 'Programme'). The Programme will not exceed 13,420,470 ordinary shares, and the maximum pecuniary amount allocated to it is £150,000,000. The end date for the Programme will be the earlier of: when one of these parameters is met; or 31 December 2019. The first half of the Programme will be executed by Morgan Stanley and the second half will be executed by Credit Suisse.

Any share purchases under the Programme will be effected within certain pre-set parameters, and in accordance with the Company's share buyback authority granted by shareholders at the Company's Annual General Meeting on 18 July 2019 (being 103,475,152 shares), the EU Market Abuse Regulation and Chapter 12 of the UK Listing Rules. The Company confirms that it currently has no inside information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
POSWGUUPBUPBGQU
Date   Source Headline
9th Oct 20249:03 amRNSDirector/PDMR Shareholding
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSNotification of Closed Period
2nd Oct 202410:47 amRNSDirector/PDMR Shareholding
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 20243:46 pmRNSTotal Voting Rights
1st Oct 20247:00 amRNSTransaction in Own Shares
30th Sep 202410:03 amRNSNon-Discretionary Share Buyback Programme
25th Sep 20244:38 pmRNSDirector/PDMR Shareholding
23rd Sep 20243:30 pmRNSDirector/PDMR Shareholding
17th Sep 20248:00 amRNSAdditional Listing
10th Sep 20244:44 pmRNSDirector/PDMR Shareholding
3rd Sep 20248:25 amRNSUK Contracts for Difference Allocation Round 6
2nd Sep 20247:00 amRNSTotal Voting Rights
30th Aug 202410:00 amRNSBlock Listing Six Monthly Return
30th Aug 20248:30 amRNSDirector/PDMR Shareholding
29th Aug 202412:00 pmRNSScrip Alternative
28th Aug 20245:12 pmRNSIssuance of Green Bond
9th Aug 202410:57 amRNSDirector/PDMR Shareholding
1st Aug 202411:32 amRNSScrip Dividend Scheme
1st Aug 20247:00 amRNSTotal Voting Rights
30th Jul 20243:41 pmRNSHolding(s) in Company
22nd Jul 20249:06 amRNSHolding(s) in Company
18th Jul 20244:16 pmRNSResult of AGM
18th Jul 20247:31 amRNSOfgem RIIO-3 Sector Specific Methodology Decision
18th Jul 20247:00 amRNSQ1 Trading Statement
10th Jul 20243:36 pmRNSDirector/PDMR Shareholding
10th Jul 20249:28 amRNSDirector/PDMR Shareholding
9th Jul 20243:26 pmRNSDirector/PDMR Shareholding
9th Jul 20247:00 amRNSSSE & partners advance 2GW offshore windfarm in NL
1st Jul 20249:25 amRNSTotal Voting Rights
14th Jun 20241:00 pmRNSAnnual Financial Report
14th Jun 202411:22 amRNSDirector/PDMR Shareholding
10th Jun 20243:40 pmRNSDirector/PDMR Shareholding
3rd Jun 20244:15 pmRNSDirector/PDMR Shareholding
3rd Jun 20247:00 amRNSTotal Voting Rights
23rd May 20249:23 amRNSDividend Timetable
23rd May 20247:01 amRNSDirector Declaration
22nd May 20247:00 amRNSPreliminary Results for the year ended 31 March 24
8th May 202412:05 pmRNSDirector/PDMR Shareholding
1st May 20247:00 amRNSTotal Voting Rights
10th Apr 20244:22 pmRNSDirector/PDMR Shareholding
9th Apr 20242:31 pmRNSDirector/PDMR Shareholding
2nd Apr 20249:37 amRNSTotal Voting Rights
27th Mar 20247:00 amRNSNotification of Closed Period
19th Mar 202411:00 amRNSSSEN Transmission welcomes ‘Beyond 2030’ plan

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.